Cell Cycle/Checkpoint

The cell cycle is consisted of 4 main phases: Gap 1 (G1), DNA replication (S), Gap 2 (G2), and mitosis (M). There are “checkpoints” mechanism regulates the transition between these phases, at the G1/S boundary, in the S-phase and during G2/M phases. Cell can only pass through these checkpoints when signaling factors are activated and free of DNA damage. Important proteins that control cell cycle events and checkpoints are cullins, cyclins, cyclin-dependent kinases (Cdks), p53 and their inhibitors etc. Cdks family (Cdk2, Cdk3, Cdk4 and Cdk6) are Ser/Thr kinases that regulate cell cycle progression in association with cyclin binding partners (cyclin D, cyclin E and cyclin A) during all four phases. p53 halts the cell cycle if the DNA is damaged and allowing time for DNA repair to progress; it can also initiate apoptosis if DNA damage is too severe to be repaired.
-   B1383 VE-8222 CitationTarget: ATM/ATRSummary: ATR inhibitor B1383 VE-8222 CitationTarget: ATM/ATRSummary: ATR inhibitor
-   B5529 SB 772077B dihydrochlorideSummary: Rho-kinase (ROCK) inhibitor B5529 SB 772077B dihydrochlorideSummary: Rho-kinase (ROCK) inhibitor
-   B1088 LY2606368Target: ChkSummary: CHK1 inhibitor B1088 LY2606368Target: ChkSummary: CHK1 inhibitor
-   A4113 ZM 447439Target: Aurora Kinases|MEK|Src|LckSummary: Aurora Kinase inhibitor,potent and selective A4113 ZM 447439Target: Aurora Kinases|MEK|Src|LckSummary: Aurora Kinase inhibitor,potent and selective
-   A3293 CDK inhibitor IISummary: CDK inhibitor A3293 CDK inhibitor IISummary: CDK inhibitor
-   A3394 Epothilone DTarget: Microtubule/TubulinSummary: Natural polyketide compound A3394 Epothilone DTarget: Microtubule/TubulinSummary: Natural polyketide compound
-   A8558 BI6727 (Volasertib)1 CitationSummary: Plk inhibitor,highly potent A8558 BI6727 (Volasertib)1 CitationSummary: Plk inhibitor,highly potent
-   A8626 ETP-46464Target: PI3K|mTOR|DNA-PK|ATM/ATRSummary: ATR inhibitor,potent and selective A8626 ETP-46464Target: PI3K|mTOR|DNA-PK|ATM/ATRSummary: ATR inhibitor,potent and selective
-   B4897 CCG-1423Target: RhoSummary: RhoA inhibitor B4897 CCG-1423Target: RhoSummary: RhoA inhibitor
-   A9908 Chk1 and MK2 Inhibitors setSummary: Chk1- and MK2 inhibitors A9908 Chk1 and MK2 Inhibitors setSummary: Chk1- and MK2 inhibitors
